Alloimmune Response to Citrullinated Shared Epitope Sequence in Patients With Rheumatoid Arthritis

Clinical trial NCT03506035 · UNKNOWN

Trial details

NCT number: NCT03506035
Sponsor: Corporacion Parc Tauli
Status: UNKNOWN
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2018-09-01
Primary completion: 2019-09-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.